CORRELATION BETWEEN THE VERIFYNOW P2Y12 ASSAY AND LIGHT TRANSMITTANCE AGGREGOMETRY TO MEASURE PLATELET P2Y12 RECEPTOR INHIBITION IN PATIENTS ON CLOPIDOGREL THERAPY

被引：0

作者：

Ueno, Masafumi ^{[1
]}

Ferreiro, Jose Luis ^{[1
]}

Dharmashankar, Kodlipet ^{[1
]}

Capranzano, Piera ^{[1
]}

Capodanno, Davide ^{[1
]}

Darlington, Andrew ^{[1
]}

Bhaloo, Desai ^{[1
]}

Charlton, Ronald ^{[1
]}

Box, Lyndon ^{[1
]}

Zenni, Martin ^{[1
]}

Guzman, Luis ^{[1
]}

Bass, Theodore ^{[1
]}

Angiolillo, Dominick J. ^{[1
]}

机构：

[1] Univ Florida, Coll Med Jacksonville, Jacksonville, FL USA

来源：

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY | 2010年 / 55卷 / 10期

关键词：

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

2504-443

引用

页数：1

共 50 条

[21] Antiplatelet Therapy n ACS Patients: Comparing Appropriate P2Y12 Inhibition by Clopidogrel to the Use of New P2Y12 Inhibitors
Ristorto, Jessica
Messas, Nathan
Marchandot, Benjamin
Kibler, Marion
Hess, Sebastien
Meyer, Nicolas
Schaeffer, Michael
Tuzin, Nicolas
Ohlmann, Patrick
Jesel, Laurence
Morel, Olivier
JOURNAL OF ATHEROSCLEROSIS AND THROMBOSIS, 2018, 25 (08) : 674 - 689
[22] Are P2Y12 reaction unit (PRU) and % inhibition index equivalent for the expression of P2Y12 inhibition by the VerifyNow® assay? Role of haematocrit and haemoglobin levels
Voisin, Sophie
Bongard, Vanina
Tidjane, Mohammed A.
Lhermusier, Thibault
Carrie, Didier
Sie, Pierre
THROMBOSIS AND HAEMOSTASIS, 2011, 106 (02) : 227 - 229
[23] P2Y12, a new platelet ADP receptor, target of clopidogrel
Savi, P
Labouret, C
Delesque, N
Guette, F
Lupker, J
Herbert, JM
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2001, 283 (02) : 379 - 383
[24] Investigation of the interaction between proton pump inhibitors and clopidogrel using VerifyNow P2Y12 assay
Lin, Sheng-Feng
Lin, Pei-Chin
Chang, Chih-Chun
Chang, Wei-Lun
Chu, Fang-Yeh
MEDICINE, 2020, 99 (50) : E23695
[25] The influence of variation in the P2Y12 receptor gene on in vitro platelet inhibition with the direct P2Y12 antagonist cangrelor
Bouman, Heleen J.
van Werkum, Jochem W.
Rudez, Goran
Leebeek, Frank W. G.
Kruit, Adrian
Hackeng, Christian M.
ten Berg, Jurrien M.
de Maat, Moniek P. M.
Ruven, Henk J. T.
THROMBOSIS AND HAEMOSTASIS, 2010, 103 (02) : 379 - 386
[26] The use of the VerifyNow P2Y12 point-of-care device to monitor platelet function across a range of P2Y12 inhibition levels following prasugrel and clopidogrel administration
Jakubowski, Joseph A.
Payne, Christopher D.
Li, Ying G.
Brandt, John T.
Small, David S.
Farid, Nagy A.
Salazar, Daniel E.
Winters, Kenneth J.
THROMBOSIS AND HAEMOSTASIS, 2008, 99 (02) : 409 - 415
[27] Hematocrit alters VerifyNow P2Y12 assay results independently of intrinsic platelet reactivity and clopidogrel responsiveness
Kakouros, N.
Kickler, T. S.
Laws, K. M.
Rade, J. J.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2013, 11 (10) : 1814 - 1822
[28] Usefulness of the VerifyNow P2Y12 assay to evaluate the antiplatelet effects of ticagrelor and clopidogrel therapies
Jeong, Young-Hoon
Bliden, Kevin P.
Antonino, Mark J.
Park, Ki-Soo
Tantry, Udaya S.
Gurbel, Paul A.
AMERICAN HEART JOURNAL, 2012, 164 (01) : 35 - 42
[29] The influence of variation in the P2Y12 receptor gene on the magnitude of in vitro platelet inhibition with the direct P2Y12 antagonist cangrelor
Bouman, H. J.
van Werkum, J. W.
Rudez, G.
Leebeek, F. W. G.
Kruit, A.
Hackeng, C. M.
ten Berg, J. M.
de Maat, M. P. M.
Ruven, H. J. T.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2009, 7 : 587 - 588
[30] P2Y12 platelet inhibition in clinical practice
Damman, Peter
Woudstra, Pier
Kuijt, Wichert J.
de Winter, Robbert J.
James, Stefan K.
JOURNAL OF THROMBOSIS AND THROMBOLYSIS, 2012, 33 (02) : 143 - 153

← 1 2 3 4 5 →